Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


Asia-Pacific Molecular Diagnostics Market is expected to register a CAGR of 11.4%

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia-Pacific Molecular Diagnostics Market, published by KBV Research, the Asia-Pacific Molecular Diagnostics Market is expected to register a CAGR of 11.4% during the forecast period (2016 - 2022). The China market dominated the Asia-Pacific Molecular Diagnostics Reagents & Kits Market by Country in 2015, and would continue to be a dominant market till 2022 growing at a CAGR of 8.8 % during the forecast period. The Japan market is expected to witness a CAGR of 7.4% during (2016 - 2022).

Additionally, The India market is expected to witness a CAGR of 11.3% during (2016 - 2022). The Polymerase Chain Reaction market dominated the Asia-Pacific Molecular Diagnostics Market by Technology in 2015, and would continue to be a dominant market till 2022. The Other Technologies market is expected to witness a CAGR of 13.4% during (2016 - 2022). The Isothermal Nucleic Acid Amplification Technology market is expected to witness a CAGR of 11.9% during (2016 - 2022).

The Infectious Diseases market dominated the Asia-Pacific Molecular Diagnostics Market by Application in 2015, and would continue to be a dominant market till 2022; thereby, achieving a market value of $1,220.4 million by 2022. The Other Applications market is expected to witness a CAGR of 15.2% during (2016 - 2022). The Oncology market is expected to witness a CAGR of 11.9% during (2016 - 2022). The Hospital & Academic Laboratories market dominated the China Molecular Diagnostics Market by End User in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 8.8 % during the forecast period.

The Reference Laboratories market is expected to witness a CAGR of 12.9% during (2016 - 2022). Additionally, The Other End Users market is expected to witness a CAGR of 14.1% during (2016 - 2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the Asia-PacificMolecular Diagnostics have been discussed in the report along with the elaborated company profiles of Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.

Full report : https://www.kbvresearch.com/asia-pacific-molecular-diagnostics-market/

Research Scope

Asia-Pacific Molecular Diagnostics Market By Product & Services

  • Reagents & Kits
  • Instruments
  • Software& Services

Asia-Pacific Molecular Diagnostics Market By Technology

  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Hybridization
  • DNA Sequencing & Next-Generation Sequencing
  • Microarray
  • Other Technologies

Asia-Pacific Molecular Diagnostics Market By Application

  • Infectious Diseases
    • Chlamydia Trachomatis & Neisseria Gonorrhoea
    • Hepatitis B & Hepatitis C
    • Human Papillomavirus
    • Human Immunodeficiency Virus
    • Tuberculosis
    • Methicillin-Resistant Staphylococcus Aurous
    • Others
  • Oncology
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Other Cancers
  • Blood Screening
  • Genetic Tests
  • Microbiology
  • Other Applications

Asia-Pacific Molecular Diagnostics Market By End User

  • Hospital & Academic Laboratories
  • Reference Laboratories
  • Other End USers

Asia-Pacific Molecular Diagnostics Market By Country

  • China Molecular Diagnostics Market
  • Japan Molecular Diagnostics Market
  • India Molecular Diagnostics Market
  • South Korea Molecular Diagnostics Market
  • Singapore Molecular Diagnostics Market
  • Australia Molecular Diagnostics Market
  • Rest of Asia-Pacific Molecular diagnostics market

Companies Profiled

  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage of Asia-Pacific Molecular Diagnostics Market
  • Highest number of market tables and figures
  • Subscription based model available
  • Free of cost quarterly updates
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Molecular Diagnostics Market  

North America Molecular Diagnostics Market  

Europe Molecular diagnostics market 

LAMEA Molecular Diagnostics Market  



SUBSCRIPTION MODEL